Marie Varloteaux

Publication Activity (10 Years)

Years Active: 2023-2023
Publications (10 Years): 3

Top Topics

Machine Learning

Hiv Infected Patients

Top Venues

Open forum infectious diseases

This page only lists publications with an associated author ORCID identifier.

Publications

Mireille Mpoudi-Etame, Tamara Tovar Sanchez, Marwân-Al-Qays Bousmah, Pierrette Omgba Bassega, Justin Olinga, Eric Mimbe, Michel Foalem, Camille Chiep, Serge Edimo, Marie Varloteaux, Raphaël Pelloquin, Nadine Lamare, Sylvie Boyer, Martine Peeters, Jacques Reynes, Alexandra Calmy, Andrew Hill, Eric Delaporte, Charles Kouanfack, null null
Durability of the Efficacy and Safety of Dolutegravir-Based and Low-Dose Efavirenz-Based Regimens for the Initial Treatment of Human Immunodeficiency Virus Type 1 Infection in Cameroon: Week 192 Data of the NAMSAL-ANRS-12313 Study. Open forum infectious diseases 10 (12) (2023)
Mireille Mpoudi-Etame, Tamara Tovar Sanchez, Marwân-Al-Qays Bousmah, Pierrette Omgba Bassega, Justin Olinga, Eric Mimbe, Michel Foalem, Camille Chiep, Serge Edimo, Marie Varloteaux, Raphaël Pelloquin, Nadine Lamare, Sylvie Boyer, Martine Peeters, Jacques Reynes, Alexandra Calmy, Andrew Hill, Eric Delaporte, Charles Kouanfack, null null
Durability of the Efficacy and Safety of Dolutegravir-Based and Low-Dose Efavirenz-Based Regimens for the Initial Treatment of Human Immunodeficiency Virus Type 1 Infection in Cameroon: Week 192 Data of the NAMSAL-ANRS-12313 Study. Open forum infectious diseases 10 (12) (2023)
Mireille Mpoudi-Etame, Tamara Tovar Sanchez, Marwân-Al-Qays Bousmah, Pierrette Omgba Bassega, Justin Olinga, Eric Mimbe, Michel Foalem, Camille Chiep, Serge Edimo, Marie Varloteaux, Raphaël Pelloquin, Nadine Lamare, Sylvie Boyer, Martine Peeters, Jacques Reynes, Alexandra Calmy, Andrew Hill, Eric Delaporte, Charles Kouanfack, null null
Durability of the Efficacy and Safety of Dolutegravir-Based and Low-Dose Efavirenz-Based Regimens for the Initial Treatment of Human Immunodeficiency Virus Type 1 Infection in Cameroon: Week 192 Data of the NAMSAL-ANRS-12313 Study. Open forum infectious diseases 10 (12) (2023)